Dr. Vasileiou on the Potential Role of ALVR109 for the Treatment of COVID-19
Spyridoula Vasileiou, PhD, discusses the potential role of ALVR109, a SARS-CoV-2 virus–specific T-cell therapy, for the treatment of coronavirus disease 2019.